Meera Mehta

353 POSTS
Meera is our dedicated writer and manager for the AI Stocks category. With her expertise in finance and a deep interest in the AI industry, Meera keeps a close eye on AI-related stocks and market trends. Her articles provide valuable insights into the financial aspects of AI, helping investors navigate this exciting and dynamic sector.

Exclusive articles:

18-Year-Old Investor Plays AI Stocks During Summer Vacation: Inside His Trade

An 18-year-old college student from Brooklyn proves that even young investors can have a good eye for picking stocks. Learn how Jason Jiang made a considerable amount of money in the stock market by investing in big tech companies like Nvidia. Discover how his strategy paid off and why big tech companies are making a comeback in the market. If you're interested in finance, following Jiang's example can help you succeed in the stock market.

AI Stock Pickers Face Dot-com Deja Vu Challenge

Investors eyeing AI stocks may be reminded of the dot-com era, but this time leaders like Nvidia and Microsoft are paving the way. However, caution is necessary to avoid another market frenzy.

Investors Battle Fed’s Hawkish Stance on AI Stocks

Investors are bullish on AI stocks despite the Fed's hawkish policy. As interest rates rise, investors remain hopeful for the future of AI technology.

Shareholders Faith in C3.ai as Stock Climbs 13% in Past Week with 162% One-Year Gain

Is C3.ai's stock surge justified? Analysts question whether the fundamentals support a 162% one-year gain. Investors, be aware of warning signs.

Retire Rich with AI Stocks

Investors looking for strong growth potential should consider AI stocks for retirement portfolios. Nvidia, Microsoft, and Amazon are three top options with stability and the ability to survive market changes.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img